Author:
METCALF C. J. E.,KLEPAC P.,FERRARI M.,GRAIS R. F.,DJIBO A.,GRENFELL B. T.
Abstract
SUMMARYMeasles vaccine efficacy is higher at 12 months than 9 months because of maternal immunity, but delaying vaccination exposes the children most vulnerable to measles mortality to infection. We explored how this trade-off changes as a function of regionally varying epidemiological drivers, e.g. demography, transmission seasonality, and vaccination coverage. High birth rates and low coverage both favour early vaccination, and initiating vaccination at 9–11 months, then switching to 12–14 months can reduce case numbers. Overall however, increasing the age-window of vaccination decreases case numbers relative to vaccinating within a narrow age-window (e.g. 9–11 months). The width of the age-window that minimizes mortality varies as a function of birth rate, vaccination coverage and patterns of access to care. Our results suggest that locally age-targeted strategies, at both national and sub-national scales, tuned to local variation in birth rate, seasonality, and access to care may substantially decrease case numbers and fatalities for routine vaccination.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Epidemiology
Reference29 articles.
1. Interpreting time-series analyses for continuous-time biological models—measles as a case study
2. 9. WHO/UNICEF. Measles mortality reduction and regional elimination: strategic plan 2001–2005. Geneva: WHO/UNICEF, 2001.
3. 27. WHO. Life tables. World Health Organization, 2008.
4. Measles vaccine efficacy in children previously vaccinated at 12 months of age;Marks;Pediatrics,1978
5. A simple model for complex dynamical transitions in epidemics;Earn;Nature,2000
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献